Inhibition of Ras prenylation: A novel approach to cancer chemotherapy

被引:120
作者
Sebti, SM
Hamilton, AD
机构
[1] UNIV PITTSBURGH, DEPT PHARMACOL, PITTSBURGH, PA 15261 USA
[2] UNIV PITTSBURGH, DEPT CHEM, PITTSBURGH, PA 15261 USA
关键词
Ras; farnesyltransferase; geranylgeranyltransferase; CAAX peptidomimetics; cancer chemotherapy; drug design;
D O I
10.1016/S0163-7258(97)00014-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The demonstration that Ras requires prenylation for its cancer-causing activity led several groups of investigators to an intense search for farnesyltransferase and geranylgeranyltransferase inhibitors as potential anticancer drugs, Rational design of small organic molecules that mimic the carboxyl terminal tetrapeptide prenylation site on Ras resulted in pharmacological agents capable of inhibiting Ras processing and selectively antagonizing oncogenic signaling, and suppressing human tumor growth in mouse models without side effects. These agents presently are undergoing advanced preclinical studies. This review describes the efforts of several groups to design, synthesize and evaluate the biological activities of several classes of prenyltransferase inhibitors. Several important issues, such as mechanism of action of prenyltransferase inhibitors and potential mechanisms of resistance to inhibition of K-Ras farnesylation, are also discussed. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:103 / 114
页数:12
相关论文
共 71 条
[61]  
SUN JZ, 1995, CANCER RES, V55, P4243
[62]   INHIBITORS OF RAS FARNESYLTRANSFERASES [J].
TAMANOI, F .
TRENDS IN BIOCHEMICAL SCIENCES, 1993, 18 (09) :349-353
[63]   BURKITT-LYMPHOMA DAUDI CELLS CONTAIN 2 DISTINCT FARNESYLTRANSFERASES WITH DIFFERENT DIVALENT-CATION REQUIREMENTS [J].
VOGT, A ;
SUN, JZ ;
QIAN, YM ;
TANCHIU, E ;
HAMILTON, AD ;
SEBTI, SM .
BIOCHEMISTRY, 1995, 34 (38) :12398-12403
[64]   A NONPEPTIDE MIMETIC OF RAS-CAAX - SELECTIVE-INHIBITION OF FARNESYLTRANSFERASE AND RAS PROCESSING [J].
VOGT, A ;
QIAN, YM ;
BLASKOVICH, MA ;
FOSSUM, RD ;
HAMILTON, AD ;
SEBTI, SM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (02) :660-664
[65]  
Vogt A, 1996, ONCOGENE, V13, P1991
[66]   ONCOGENIC RAS ACTIVATES C-JUN VIA A SEPARATE PATHWAY FROM THE ACTIVATION OF EXTRACELLULAR SIGNAL-REGULATED KINASES [J].
WESTWICK, JK ;
COX, AD ;
DER, CJ ;
COBB, MH ;
HIBI, M ;
KARIN, M ;
BRENNER, DA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (13) :6030-6034
[67]   A-substituted piperazines as constrained amino acids. Application to the synthesis of potent, non carboxylic acid inhibitors of farnesyltransferase [J].
Williams, TM ;
Ciccarone, TM ;
MacTough, SC ;
Bock, RL ;
Conner, MW ;
Davide, JP ;
Hamilton, K ;
Koblan, KS ;
Kohl, NE ;
Kral, AM ;
Mosser, SD ;
Omer, CA ;
Pompliano, DL ;
Rands, E ;
Schaber, MD ;
Shah, D ;
Wilson, FR ;
Gibbs, JB ;
Graham, SL ;
Hartman, GD ;
Oliff, AI ;
Smith, RL .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (07) :1345-1348
[68]   THE P21 RAS C-TERMINUS IS REQUIRED FOR TRANSFORMATION AND MEMBRANE ASSOCIATION [J].
WILLUMSEN, BM ;
CHRISTENSEN, A ;
HUBBERT, NL ;
PAPAGEORGE, AG ;
LOWY, DR .
NATURE, 1984, 310 (5978) :583-586
[69]   A PROTEIN GERANYLGERANYLTRANSFERASE FROM BOVINE BRAIN - IMPLICATIONS FOR PROTEIN PRENYLATION SPECIFICITY [J].
YOKOYAMA, K ;
GOODWIN, GW ;
GHOMASHCHI, F ;
GLOMSET, JA ;
GELB, MH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (12) :5302-5306
[70]  
YOKOYAMA K, 1993, J BIOL CHEM, V268, P4055